| Literature DB >> 3573995 |
J J Belch, A R Saniabadi, K McLaughlin, C D Forbes.
Abstract
A saturated fat meal was given to 10 normal males both before and after pretreatment with UK38,485, a thromboxane synthetase inhibitor (Dazmegrel, Pfizer Central Research, Sandwich, Kent, United Kingdom). Following the fat meal at 2 and 4 hr there was laboratory evidence of platelet activation. Dazmegrel lowered baseline platelet activity and lessened platelet activation following the fat meal. This drug should be investigated further as a potential antithrombotic agent.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3573995 DOI: 10.1007/bf02537296
Source DB: PubMed Journal: Lipids ISSN: 0024-4201 Impact factor: 1.880